ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...

A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment ...

Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...

For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently ...

Nonlinear improvement seen in relative benefit of distant metastasis, OS, with reduced benefits beyond nine to 12 months of ADT.

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

A new survey shows most construction workers delay or avoid prostate cancer screenings due to stigma and knowledge gaps. As ...

Nigeria records over 18,000 new prostate cancer cases annually, accounting for the highest cancer burden among men in the country.

Using cancer’s own survival tricks against it, scientists may have found a new way to stay one step ahead of the disease.

For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has ...

# A FORMER Royal Bahamas Defence Force officer facing up to 20 years in prison for his role in a major cocaine trafficking ...

Here are the top 5 stories from 2025 about the advancements in prostate, kidney, and bladder cancers.